Effectiveness of a community-based intervention for weight loss on cardiometabolic risk factors among overweight and obese women in a low socio-economic urban community: findings of the MyBFF@home

Table 2 Changes in cardiometabolic risk factors in control and intervention group overall (Baseline-12 month)

Outcome measures	Estimated mean difference (95% CI)^§ (Baseline – 12 month)		Intervention effect (between group x Time)
Outcome measures	Control	Intervention	F	p-value	Partial eta squared
FPG (mmol/L)	− 0.12	− 0.30**	0.894	0.410	0.008
FPG (mmol/L)	(− 0.39, 0.15)	(− 0.54, − 0.06)	0.894	0.410	0.008
Triglycerides (mmol/L)	0.05	0.00	0.152	0.859	0.001
Triglycerides (mmol/L)	(− 0.10, 0.19)	(− 0.18, 0.19)	0.152	0.859	0.001
Total cholesterol (mmol/L)	− 0.06	− 0.26	3.131	0.046*	0.026
Total cholesterol (mmol/L)	(− 0.28, 0.17)	(− 0.47, − 0.06) **	3.131	0.046*	0.026
HDL-C (mmol/L) *	− 0.09***	− 0.05*	0.621	0.538	0.003
HDL-C (mmol/L) *	(− 0.14, − 0.04)	(− 0.10, − 0.00)	0.621	0.538	0.003
LDL-C (mmol/L)	− 0.54***	− 0.39***	0.543	0.582	0.005
LDL-C (mmol/L)	(− 0.80, − 0.27)	(− 0.62, − 0.17)	0.543	0.582	0.005
LDL-C/HDL-C ratio	− 0.12	− 0.12	0.247	0.781	0.002
LDL-C/HDL-C ratio	(− 0.36, 0.12)	(− 0.31, 0.07)	0.247	0.781	0.002
TC/HDL-C ratio^ψ	0.31**	0.04	2.493	0.089	0.020
TC/HDL-C ratio^ψ	(0.08, 0.54)	(− 0.14, 0.22)	2.493	0.089	0.020

Notes: Data are presented as estimated mean differences (95% CI)
Boldface indicates statistical significance, *p < 0.05, **p < 0.01, ***p < 0.001
^§Estimated mean differences obtained using repeated measures ANOVA adjusting for age, education level and baseline weight, significance at p < 0.05
^ψAdjusted for baseline values
Abbreviations: CI confidence interval, FPG fasting plasma glucose, LDL-C low density lipoprotein-cholesterol, HDL-C high density lipoprotein-cholesterol

ISSN: 1472-6874